中/EN
中文繁體
English
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company Presentations
Stock Quotes & Charts
Analyst Coverage
FAQs
IR Contact
Corporate
Investor Relations
IR Home
Corporate Overview
Financial Highlights
Financial Reports
ESG Reports
Regulatory Filings
Press Releases
Company
Presentations
Stock Quotes &
Charts
Analyst Coverage
FAQs
IR Contact
Latest News
APR
24
UPDATED INFORMATION ON THE GROUP'S PRODUCT AMOXICILLIN CLAVULANATE POTASSIUM TABLETS
APR
23
VOLUNTARY ANNOUNCEMENT PROPOSED BID-WINNING RESULTS OF NATIONAL CENTRALISED PROCUREMENT OF PHARMACEUTICALS (SPECIALISING RENEWAL IN INSULIN)
APR
03
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 March 2024
2023
Interim Report
PDF
ESG Report 2022
Environment
Social
Governance
Presentation
Investor Information
Regulatory Filings
Corporate Governance
Stock Quotes & Charts
FAQs
IR Contact
Address
6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong
Email
tulir@tul.com.hk